Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Anti-Cancer Drug Market 2018, Forecast to 2023

January 2019 | 151 pages | ID: GEBA34F1674EN
GlobalInfoResearch

Abstracts

Anticancer drug, also called antineoplastic drug, any drug that is effective in the treatment of malignant, or cancerous, disease. There are several major classes of anticancer drugs; these include alkylating agents, antimetabolites, natural products, and hormones.

Scope of the Report:

This report focuses on the Anti-Cancer Drug in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
China and India are expected to offer good opportunities an account of improvement in healthcare infrastructure. In Africa, industry is expected to drive at lower rate on account of lack of healthcare infrastructure, expensive medical services and lack of consumer awareness.
Central & South America is expected to drive at stable rates on account of costly medicines coupled with minimal awareness initiatives by regional government. Global market is also expected to have legal conflicts arising on account of patents which in turn are expected to negatively impact overall industry.

The worldwide market for Anti-Cancer Drug is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

• Merck
• Bristol-Myers Squibb
• Bayer
• GlaxoSmithKline
• Novartis
• Sanofi
• Pfizer
• Amgen
• Celgene Corporation
• Ariad Pharmaceuticals
• Eli Lilly
• Hoffmann-La Roche Ltd.
• AstraZeneca
• Boehringer Ingelheim GmbH
• Teva Pharmaceuticals

Market Segment by Regions, regional analysis covers

• North America (United States, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Colombia etc.)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

• Avastin
• Rituxan
• Herceptin
• Alimta

Market Segment by Applications, can be divided into

• Hospital
• Clinic
• Home Care

There are 15 Chapters to deeply display the global Anti-Cancer Drug market.

Chapter 1, to describe Anti-Cancer Drug Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Anti-Cancer Drug, with sales, revenue, and price of Anti-Cancer Drug, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Anti-Cancer Drug, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Anti-Cancer Drug market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Anti-Cancer Drug sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Contents

1 MARKET OVERVIEW

1.1 Anti-Cancer Drug Introduction
1.2 Market Analysis by Type
  1.2.1 Avastin
  1.2.2 Rituxan
  1.2.3 Herceptin
  1.2.4 Alimta
1.3 Market Analysis by Applications
  1.3.1 Hospital
  1.3.2 Clinic
  1.3.3 Home Care
1.4 Market Analysis by Regions
  1.4.1 North America (United States, Canada and Mexico)
    1.4.1.1 United States Market States and Outlook (2013-2023)
    1.4.1.2 Canada Market States and Outlook (2013-2023)
    1.4.1.3 Mexico Market States and Outlook (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy)
    1.4.2.1 Germany Market States and Outlook (2013-2023)
    1.4.2.2 France Market States and Outlook (2013-2023)
    1.4.2.3 UK Market States and Outlook (2013-2023)
    1.4.2.4 Russia Market States and Outlook (2013-2023)
    1.4.2.5 Italy Market States and Outlook (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
    1.4.3.1 China Market States and Outlook (2013-2023)
    1.4.3.2 Japan Market States and Outlook (2013-2023)
    1.4.3.3 Korea Market States and Outlook (2013-2023)
    1.4.3.4 India Market States and Outlook (2013-2023)
    1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
  1.4.4 South America, Middle East and Africa
    1.4.4.1 Brazil Market States and Outlook (2013-2023)
    1.4.4.2 Egypt Market States and Outlook (2013-2023)
    1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
    1.4.4.4 South Africa Market States and Outlook (2013-2023)
    1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
  1.5.1 Market Opportunities
  1.5.2 Market Risk
  1.5.3 Market Driving Force

2 MANUFACTURERS PROFILES

2.1 Merck
  2.1.1 Business Overview
    2.1.1.1 Merck Description
    2.1.1.2 Merck Headquarter, Main Business and Finance Overview
  2.1.2 Merck Anti-Cancer Drug Product Introduction
    2.1.2.1 Anti-Cancer Drug Production Bases, Sales Regions and Major Competitors
    2.1.2.2 Anti-Cancer Drug Product Information
  2.1.3 Merck Anti-Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.1.3.1 Merck Anti-Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.1.3.2 Global Merck Anti-Cancer Drug Market Share in 2017
2.2 Bristol-Myers Squibb
  2.2.1 Business Overview
    2.2.1.1 Bristol-Myers Squibb Description
    2.2.1.2 Bristol-Myers Squibb Headquarter, Main Business and Finance Overview
  2.2.2 Bristol-Myers Squibb Anti-Cancer Drug Product Introduction
    2.2.2.1 Anti-Cancer Drug Production Bases, Sales Regions and Major Competitors
    2.2.2.2 Anti-Cancer Drug Product Information
  2.2.3 Bristol-Myers Squibb Anti-Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.2.3.1 Bristol-Myers Squibb Anti-Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.2.3.2 Global Bristol-Myers Squibb Anti-Cancer Drug Market Share in 2017
2.3 Bayer
  2.3.1 Business Overview
    2.3.1.1 Bayer Description
    2.3.1.2 Bayer Headquarter, Main Business and Finance Overview
  2.3.2 Bayer Anti-Cancer Drug Product Introduction
    2.3.2.1 Anti-Cancer Drug Production Bases, Sales Regions and Major Competitors
    2.3.2.2 Anti-Cancer Drug Product Information
  2.3.3 Bayer Anti-Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.3.3.1 Bayer Anti-Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.3.3.2 Global Bayer Anti-Cancer Drug Market Share in 2017
2.4 GlaxoSmithKline
  2.4.1 Business Overview
    2.4.1.1 GlaxoSmithKline Description
    2.4.1.2 GlaxoSmithKline Headquarter, Main Business and Finance Overview
  2.4.2 GlaxoSmithKline Anti-Cancer Drug Product Introduction
    2.4.2.1 Anti-Cancer Drug Production Bases, Sales Regions and Major Competitors
    2.4.2.2 Anti-Cancer Drug Product Information
  2.4.3 GlaxoSmithKline Anti-Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.4.3.1 GlaxoSmithKline Anti-Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.4.3.2 Global GlaxoSmithKline Anti-Cancer Drug Market Share in 2017
2.5 Novartis
  2.5.1 Business Overview
    2.5.1.1 Novartis Description
    2.5.1.2 Novartis Headquarter, Main Business and Finance Overview
  2.5.2 Novartis Anti-Cancer Drug Product Introduction
    2.5.2.1 Anti-Cancer Drug Production Bases, Sales Regions and Major Competitors
    2.5.2.2 Anti-Cancer Drug Product Information
  2.5.3 Novartis Anti-Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.5.3.1 Novartis Anti-Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.5.3.2 Global Novartis Anti-Cancer Drug Market Share in 2017
2.6 Sanofi
  2.6.1 Business Overview
    2.6.1.1 Sanofi Description
    2.6.1.2 Sanofi Headquarter, Main Business and Finance Overview
  2.6.2 Sanofi Anti-Cancer Drug Product Introduction
    2.6.2.1 Anti-Cancer Drug Production Bases, Sales Regions and Major Competitors
    2.6.2.2 Anti-Cancer Drug Product Information
  2.6.3 Sanofi Anti-Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.6.3.1 Sanofi Anti-Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.6.3.2 Global Sanofi Anti-Cancer Drug Market Share in 2017
2.7 Pfizer
  2.7.1 Business Overview
    2.7.1.1 Pfizer Description
    2.7.1.2 Pfizer Headquarter, Main Business and Finance Overview
  2.7.2 Pfizer Anti-Cancer Drug Product Introduction
    2.7.2.1 Anti-Cancer Drug Production Bases, Sales Regions and Major Competitors
    2.7.2.2 Anti-Cancer Drug Product Information
  2.7.3 Pfizer Anti-Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.7.3.1 Pfizer Anti-Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.7.3.2 Global Pfizer Anti-Cancer Drug Market Share in 2017
2.8 Amgen
  2.8.1 Business Overview
    2.8.1.1 Amgen Description
    2.8.1.2 Amgen Headquarter, Main Business and Finance Overview
  2.8.2 Amgen Anti-Cancer Drug Product Introduction
    2.8.2.1 Anti-Cancer Drug Production Bases, Sales Regions and Major Competitors
    2.8.2.2 Anti-Cancer Drug Product Information
  2.8.3 Amgen Anti-Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.8.3.1 Amgen Anti-Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.8.3.2 Global Amgen Anti-Cancer Drug Market Share in 2017
2.9 Celgene Corporation
  2.9.1 Business Overview
    2.9.1.1 Celgene Corporation Description
    2.9.1.2 Celgene Corporation Headquarter, Main Business and Finance Overview
  2.9.2 Celgene Corporation Anti-Cancer Drug Product Introduction
    2.9.2.1 Anti-Cancer Drug Production Bases, Sales Regions and Major Competitors
    2.9.2.2 Anti-Cancer Drug Product Information
  2.9.3 Celgene Corporation Anti-Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.9.3.1 Celgene Corporation Anti-Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.9.3.2 Global Celgene Corporation Anti-Cancer Drug Market Share in 2017
2.10 Ariad Pharmaceuticals
  2.10.1 Business Overview
    2.10.1.1 Ariad Pharmaceuticals Description
    2.10.1.2 Ariad Pharmaceuticals Headquarter, Main Business and Finance Overview
  2.10.2 Ariad Pharmaceuticals Anti-Cancer Drug Product Introduction
    2.10.2.1 Anti-Cancer Drug Production Bases, Sales Regions and Major Competitors
    2.10.2.2 Anti-Cancer Drug Product Information
  2.10.3 Ariad Pharmaceuticals Anti-Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.10.3.1 Ariad Pharmaceuticals Anti-Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.10.3.2 Global Ariad Pharmaceuticals Anti-Cancer Drug Market Share in 2017
2.11 Eli Lilly
  2.11.1 Business Overview
  2.11.2 Eli Lilly Anti-Cancer Drug Product Introduction
  2.11.3 Eli Lilly Anti-Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Hoffmann-La Roche Ltd.
  2.12.1 Business Overview
  2.12.2 Hoffmann-La Roche Ltd. Anti-Cancer Drug Product Introduction
  2.12.3 Hoffmann-La Roche Ltd. Anti-Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 AstraZeneca
  2.13.1 Business Overview
  2.13.2 AstraZeneca Anti-Cancer Drug Product Introduction
  2.13.3 AstraZeneca Anti-Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 Boehringer Ingelheim GmbH
  2.14.1 Business Overview
  2.14.2 Boehringer Ingelheim GmbH Anti-Cancer Drug Product Introduction
  2.14.3 Boehringer Ingelheim GmbH Anti-Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.15 Teva Pharmaceuticals
  2.15.1 Business Overview
  2.15.2 Teva Pharmaceuticals Anti-Cancer Drug Product Introduction
  2.15.3 Teva Pharmaceuticals Anti-Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL ANTI-CANCER DRUG MARKET COMPETITION, BY MANUFACTURER

3.1 Global Anti-Cancer Drug Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Anti-Cancer Drug Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global Anti-Cancer Drug Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
  3.4.1 Top 3 Anti-Cancer Drug Manufacturer Market Share in 2017
  3.4.2 Top 5 Anti-Cancer Drug Manufacturer Market Share in 2017
3.5 Market Competition Trend

4 GLOBAL ANTI-CANCER DRUG MARKET ANALYSIS BY REGIONS

4.1 Global Anti-Cancer Drug Sales, Revenue and Market Share by Regions
  4.1.1 Global Anti-Cancer Drug Sales by Regions (2013-2018)
  4.1.2 Global Anti-Cancer Drug Revenue by Regions (2013-2018)
4.2 North America Anti-Cancer Drug Sales, Revenue and Growth Rate (2013-2018)
4.3 Europe Anti-Cancer Drug Sales, Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Anti-Cancer Drug Sales, Revenue and Growth Rate (2013-2018)
4.5 South America Anti-Cancer Drug Sales, Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Anti-Cancer Drug Sales, Revenue and Growth Rate (2013-2018)

5 NORTH AMERICA ANTI-CANCER DRUG BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

5.1 North America Anti-Cancer Drug Sales, Revenue and Market Share by Countries
  5.1.1 North America Anti-Cancer Drug Sales by Countries (2013-2018)
  5.1.2 North America Anti-Cancer Drug Revenue by Countries (2013-2018)
  5.1.3 United States Anti-Cancer Drug Sales and Growth Rate (2013-2018)
  5.1.4 Canada Anti-Cancer Drug Sales and Growth Rate (2013-2018)
  5.1.5 Mexico Anti-Cancer Drug Sales and Growth Rate (2013-2018)
5.2 North America Anti-Cancer Drug Sales and Revenue (Value) by Manufacturers (2016-2017)
  5.2.1 North America Anti-Cancer Drug Sales by Manufacturers (2016-2017)
  5.2.2 North America Anti-Cancer Drug Revenue by Manufacturers (2016-2017)
5.3 North America Anti-Cancer Drug Sales, Revenue and Market Share by Type (2013-2018)
  5.3.1 North America Anti-Cancer Drug Sales and Sales Share by Type (2013-2018)
  5.3.2 North America Anti-Cancer Drug Revenue and Revenue Share by Type (2013-2018)
5.4 North America Anti-Cancer Drug Sales, Revenue and Market Share by Application (2013-2018)
  5.4.1 North America Anti-Cancer Drug Sales and Sales Share by Application (2013-2018)
  5.4.2 North America Anti-Cancer Drug Revenue and Revenue Share by Application (2013-2018)

6 EUROPE ANTI-CANCER DRUG BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

6.1 Europe Anti-Cancer Drug Sales, Revenue and Market Share by Countries
  6.1.1 Europe Anti-Cancer Drug Sales by Countries (2013-2018)
  6.1.2 Europe Anti-Cancer Drug Revenue by Countries (2013-2018)
  6.1.3 Germany Anti-Cancer Drug Sales and Growth Rate (2013-2018)
  6.1.4 UK Anti-Cancer Drug Sales and Growth Rate (2013-2018)
  6.1.5 France Anti-Cancer Drug Sales and Growth Rate (2013-2018)
  6.1.6 Russia Anti-Cancer Drug Sales and Growth Rate (2013-2018)
  6.1.7 Italy Anti-Cancer Drug Sales and Growth Rate (2013-2018)
6.2 Europe Anti-Cancer Drug Sales and Revenue (Value) by Manufacturers (2016-2017)
  6.2.1 Europe Anti-Cancer Drug Sales by Manufacturers (2016-2017)
  6.2.2 Europe Anti-Cancer Drug Revenue by Manufacturers (2016-2017)
6.3 Europe Anti-Cancer Drug Sales, Revenue and Market Share by Type (2013-2018)
  6.3.1 Europe Anti-Cancer Drug Sales and Sales Share by Type (2013-2018)
  6.3.2 Europe Anti-Cancer Drug Revenue and Revenue Share by Type (2013-2018)
6.4 Europe Anti-Cancer Drug Sales, Revenue and Market Share by Application (2013-2018)
  6.4.1 Europe Anti-Cancer Drug Sales and Sales Share by Application (2013-2018)
  6.4.2 Europe Anti-Cancer Drug Revenue and Revenue Share by Application (2013-2018)

7 ASIA-PACIFIC ANTI-CANCER DRUG BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

7.1 Asia-Pacific Anti-Cancer Drug Sales, Revenue and Market Share by Countries
  7.1.1 Asia-Pacific Anti-Cancer Drug Sales by Countries (2013-2018)
  7.1.2 Asia-Pacific Anti-Cancer Drug Revenue by Countries (2013-2018)
  7.1.3 China Anti-Cancer Drug Sales and Growth Rate (2013-2018)
  7.1.4 Japan Anti-Cancer Drug Sales and Growth Rate (2013-2018)
  7.1.5 Korea Anti-Cancer Drug Sales and Growth Rate (2013-2018)
  7.1.6 India Anti-Cancer Drug Sales and Growth Rate (2013-2018)
  7.1.7 Southeast Asia Anti-Cancer Drug Sales and Growth Rate (2013-2018)
7.2 Asia-Pacific Anti-Cancer Drug Sales and Revenue (Value) by Manufacturers (2016-2017)
  7.2.1 Asia-Pacific Anti-Cancer Drug Sales by Manufacturers (2016-2017)
  7.2.2 Asia-Pacific Anti-Cancer Drug Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific Anti-Cancer Drug Sales, Revenue and Market Share by Type (2013-2018)
  7.3.1 Asia-Pacific Anti-Cancer Drug Sales and Sales Share by Type (2013-2018)
  7.3.2 Asia-Pacific Anti-Cancer Drug Revenue and Revenue Share by Type (2013-2018)
7.4 Asia-Pacific Anti-Cancer Drug Sales, Revenue and Market Share by Application (2013-2018)
  7.4.1 Asia-Pacific Anti-Cancer Drug Sales and Sales Share by Application (2013-2018)
  7.4.2 Asia-Pacific Anti-Cancer Drug Revenue and Revenue Share by Application (2013-2018)

8 SOUTH AMERICA ANTI-CANCER DRUG BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

8.1 South America Anti-Cancer Drug Sales, Revenue and Market Share by Countries
  8.1.1 South America Anti-Cancer Drug Sales by Countries (2013-2018)
  8.1.2 South America Anti-Cancer Drug Revenue by Countries (2013-2018)
  8.1.3 Brazil Anti-Cancer Drug Sales and Growth Rate (2013-2018)
  8.1.4 Argentina Anti-Cancer Drug Sales and Growth Rate (2013-2018)
  8.1.5 Colombia Anti-Cancer Drug Sales and Growth Rate (2013-2018)
8.2 South America Anti-Cancer Drug Sales and Revenue (Value) by Manufacturers (2016-2017)
  8.2.1 South America Anti-Cancer Drug Sales by Manufacturers (2016-2017)
  8.2.2 South America Anti-Cancer Drug Revenue by Manufacturers (2016-2017)
8.3 South America Anti-Cancer Drug Sales, Revenue and Market Share by Type (2013-2018)
  8.3.1 South America Anti-Cancer Drug Sales and Sales Share by Type (2013-2018)
  8.3.2 South America Anti-Cancer Drug Revenue and Revenue Share by Type (2013-2018)
8.4 South America Anti-Cancer Drug Sales, Revenue and Market Share by Application (2013-2018)
  8.4.1 South America Anti-Cancer Drug Sales and Sales Share by Application (2013-2018)
  8.4.2 South America Anti-Cancer Drug Revenue and Revenue Share by Application (2013-2018)

9 MIDDLE EAST AND AFRICA ANTI-CANCER DRUG BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

9.1 Middle East and Africa Anti-Cancer Drug Sales, Revenue and Market Share by Countries
  9.1.1 Middle East and Africa Anti-Cancer Drug Sales by Countries (2013-2018)
  9.1.2 Middle East and Africa Anti-Cancer Drug Revenue by Countries (2013-2018)
  9.1.3 Saudi Arabia Anti-Cancer Drug Sales and Growth Rate (2013-2018)
  9.1.4 UAE Anti-Cancer Drug Sales and Growth Rate (2013-2018)
  9.1.5 Egypt Anti-Cancer Drug Sales and Growth Rate (2013-2018)
  9.1.6 Nigeria Anti-Cancer Drug Sales and Growth Rate (2013-2018)
  9.1.7 South Africa Anti-Cancer Drug Sales and Growth Rate (2013-2018)
9.2 Middle East and Africa Anti-Cancer Drug Sales and Revenue (Value) by Manufacturers (2016-2017)
  9.2.1 Middle East and Africa Anti-Cancer Drug Sales by Manufacturers (2016-2017)
  9.2.2 Middle East and Africa Anti-Cancer Drug Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa Anti-Cancer Drug Sales, Revenue and Market Share by Type (2013-2018)
  9.3.1 Middle East and Africa Anti-Cancer Drug Sales and Sales Share by Type (2013-2018)
  9.3.1 Middle East and Africa Anti-Cancer Drug Revenue and Revenue Share by Type (2013-2018)
9.4 Middle East and Africa Anti-Cancer Drug Sales, Revenue and Market Share by Application (2013-2018)
  9.4.1 Middle East and Africa Anti-Cancer Drug Sales and Sales Share by Application (2013-2018)
  9.4.2 Middle East and Africa Anti-Cancer Drug Revenue and Revenue Share by Application (2013-2018)

10 GLOBAL ANTI-CANCER DRUG MARKET SEGMENT BY TYPE

10.1 Global Anti-Cancer Drug Sales, Revenue and Market Share by Type (2013-2018)
  10.1.1 Global Anti-Cancer Drug Sales and Market Share by Type (2013-2018)
  10.1.2 Global Anti-Cancer Drug Revenue and Market Share by Type (2013-2018)
10.2 Avastin Sales Growth and Price
  10.2.1 Global Avastin Sales Growth (2013-2018)
  10.2.2 Global Avastin Price (2013-2018)
10.3 Rituxan Sales Growth and Price
  10.3.1 Global Rituxan Sales Growth (2013-2018)
  10.3.2 Global Rituxan Price (2013-2018)
10.4 Herceptin Sales Growth and Price
  10.4.1 Global Herceptin Sales Growth (2013-2018)
  10.4.2 Global Herceptin Price (2013-2018)
10.5 Alimta Sales Growth and Price
  10.5.1 Global Alimta Sales Growth (2013-2018)
  10.5.2 Global Alimta Price (2013-2018)

11 GLOBAL ANTI-CANCER DRUG MARKET SEGMENT BY APPLICATION

11.1 Global Anti-Cancer Drug Sales Market Share by Application (2013-2018)
11.2 Hospital Sales Growth (2013-2018)
11.3 Clinic Sales Growth (2013-2018)
11.4 Home Care Sales Growth (2013-2018)

12 ANTI-CANCER DRUG MARKET FORECAST (2018-2023)

12.1 Global Anti-Cancer Drug Sales, Revenue and Growth Rate (2018-2023)
12.2 Anti-Cancer Drug Market Forecast by Regions (2018-2023)
  12.2.1 North America Anti-Cancer Drug Market Forecast (2018-2023)
  12.2.2 Europe Anti-Cancer Drug Market Forecast (2018-2023)
  12.2.3 Asia-Pacific Anti-Cancer Drug Market Forecast (2018-2023)
  12.2.4 South America Anti-Cancer Drug Market Forecast (2018-2023)
  12.2.5 Middle East and Africa Anti-Cancer Drug Market Forecast (2018-2023)
12.3 Anti-Cancer Drug Market Forecast by Type (2018-2023)
  12.3.1 Global Anti-Cancer Drug Sales Forecast by Type (2018-2023)
  12.3.2 Global Anti-Cancer Drug Market Share Forecast by Type (2018-2023)
12.4 Anti-Cancer Drug Market Forecast by Application (2018-2023)
  12.4.1 Global Anti-Cancer Drug Sales Forecast by Application (2018-2023)
  12.4.2 Global Anti-Cancer Drug Market Share Forecast by Application (2018-2023)

13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS

13.1 Sales Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers

14 RESEARCH FINDINGS AND CONCLUSION

15 APPENDIX

15.1 Methodology
15.2 Data

List Of Tables

LIST OF TABLES AND FIGURES

Figure Anti-Cancer Drug Picture
Table Product Specifications of Anti-Cancer Drug
Figure Global Anti-Cancer Drug CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (USD Million)
Figure Global Anti-Cancer Drug CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (Sales)
Figure Global Sales Market Share of Anti-Cancer Drug by Types in 2017
Figure Avastin Picture
Table Major Manufacturers of Avastin
Figure Rituxan Picture
Table Major Manufacturers of Rituxan
Figure Herceptin Picture
Table Major Manufacturers of Herceptin
Figure Alimta Picture
Table Major Manufacturers of Alimta
Figure Anti-Cancer Drug Sales Market Share by Applications in 2017
Figure Hospital Picture
Figure Clinic Picture
Figure Home Care Picture
Figure United States Anti-Cancer Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Anti-Cancer Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Anti-Cancer Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Anti-Cancer Drug Revenue (Value) and Growth Rate (2013-2023)
Figure France Anti-Cancer Drug Revenue (Value) and Growth Rate (2013-2023)
Figure UK Anti-Cancer Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Anti-Cancer Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Anti-Cancer Drug Revenue (Value) and Growth Rate (2013-2023)
Figure China Anti-Cancer Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Anti-Cancer Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Anti-Cancer Drug Revenue (Value) and Growth Rate (2013-2023)
Figure India Anti-Cancer Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Anti-Cancer Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Anti-Cancer Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Anti-Cancer Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Anti-Cancer Drug Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Anti-Cancer Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Anti-Cancer Drug Revenue (Value) and Growth Rate (2013-2023)
Table Merck Headquarter, Established, Main Business and Finance Overview (2017)
Table Merck Anti-Cancer Drug Production Bases, Sales Regions and Major Competitors
Table Merck Anti-Cancer Drug Product
Table Merck Anti-Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Merck Anti-Cancer Drug Sales Market Share in 2017
Figure Global Merck Anti-Cancer Drug Revenue Market Share in 2017
Table Bristol-Myers Squibb Headquarter, Established, Main Business and Finance Overview (2017)
Table Bristol-Myers Squibb Anti-Cancer Drug Production Bases, Sales Regions and Major Competitors
Table Bristol-Myers Squibb Anti-Cancer Drug Product
Table Bristol-Myers Squibb Anti-Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Bristol-Myers Squibb Anti-Cancer Drug Sales Market Share in 2017
Figure Global Bristol-Myers Squibb Anti-Cancer Drug Revenue Market Share in 2017
Table Bayer Headquarter, Established, Main Business and Finance Overview (2017)
Table Bayer Anti-Cancer Drug Production Bases, Sales Regions and Major Competitors
Table Bayer Anti-Cancer Drug Product
Table Bayer Anti-Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Bayer Anti-Cancer Drug Sales Market Share in 2017
Figure Global Bayer Anti-Cancer Drug Revenue Market Share in 2017
Table GlaxoSmithKline Headquarter, Established, Main Business and Finance Overview (2017)
Table GlaxoSmithKline Anti-Cancer Drug Production Bases, Sales Regions and Major Competitors
Table GlaxoSmithKline Anti-Cancer Drug Product
Table GlaxoSmithKline Anti-Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global GlaxoSmithKline Anti-Cancer Drug Sales Market Share in 2017
Figure Global GlaxoSmithKline Anti-Cancer Drug Revenue Market Share in 2017
Table Novartis Headquarter, Established, Main Business and Finance Overview (2017)
Table Novartis Anti-Cancer Drug Production Bases, Sales Regions and Major Competitors
Table Novartis Anti-Cancer Drug Product
Table Novartis Anti-Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Novartis Anti-Cancer Drug Sales Market Share in 2017
Figure Global Novartis Anti-Cancer Drug Revenue Market Share in 2017
Table Sanofi Headquarter, Established, Main Business and Finance Overview (2017)
Table Sanofi Anti-Cancer Drug Production Bases, Sales Regions and Major Competitors
Table Sanofi Anti-Cancer Drug Product
Table Sanofi Anti-Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Sanofi Anti-Cancer Drug Sales Market Share in 2017
Figure Global Sanofi Anti-Cancer Drug Revenue Market Share in 2017
Table Pfizer Headquarter, Established, Main Business and Finance Overview (2017)
Table Pfizer Anti-Cancer Drug Production Bases, Sales Regions and Major Competitors
Table Pfizer Anti-Cancer Drug Product
Table Pfizer Anti-Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Pfizer Anti-Cancer Drug Sales Market Share in 2017
Figure Global Pfizer Anti-Cancer Drug Revenue Market Share in 2017
Table Amgen Headquarter, Established, Main Business and Finance Overview (2017)
Table Amgen Anti-Cancer Drug Production Bases, Sales Regions and Major Competitors
Table Amgen Anti-Cancer Drug Product
Table Amgen Anti-Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Amgen Anti-Cancer Drug Sales Market Share in 2017
Figure Global Amgen Anti-Cancer Drug Revenue Market Share in 2017
Table Celgene Corporation Headquarter, Established, Main Business and Finance Overview (2017)
Table Celgene Corporation Anti-Cancer Drug Production Bases, Sales Regions and Major Competitors
Table Celgene Corporation Anti-Cancer Drug Product
Table Celgene Corporation Anti-Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Celgene Corporation Anti-Cancer Drug Sales Market Share in 2017
Figure Global Celgene Corporation Anti-Cancer Drug Revenue Market Share in 2017
Table Ariad Pharmaceuticals Headquarter, Established, Main Business and Finance Overview (2017)
Table Ariad Pharmaceuticals Anti-Cancer Drug Production Bases, Sales Regions and Major Competitors
Table Ariad Pharmaceuticals Anti-Cancer Drug Product
Table Ariad Pharmaceuticals Anti-Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Ariad Pharmaceuticals Anti-Cancer Drug Sales Market Share in 2017
Figure Global Ariad Pharmaceuticals Anti-Cancer Drug Revenue Market Share in 2017
Table Eli Lilly
Table Eli Lilly Anti-Cancer Drug
Table Hoffmann-La Roche Ltd.
Table Hoffmann-La Roche Ltd. Anti-Cancer Drug
Table AstraZeneca
Table AstraZeneca Anti-Cancer Drug
Table Boehringer Ingelheim GmbH
Table Boehringer Ingelheim GmbH Anti-Cancer Drug
Table Teva Pharmaceuticals
Table Teva Pharmaceuticals Anti-Cancer Drug
Table Global Anti-Cancer Drug Sales by Manufacturer (2016-2017)
Figure Global Anti-Cancer Drug Sales Market Share by Manufacturer in 2016
Figure Global Anti-Cancer Drug Sales Market Share by Manufacturer in 2017
Table Global Anti-Cancer Drug Revenue by Manufacturer (2016-2017)
Figure Global Anti-Cancer Drug Revenue Market Share by Manufacturer in 2016
Figure Global Anti-Cancer Drug Revenue Market Share by Manufacturer in 2017
Table Global Anti-Cancer Drug Price by Manufacturer (2016-2017)
Figure Top 3 Anti-Cancer Drug Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Anti-Cancer Drug Manufacturer (Revenue) Market Share in 2017
Figure Global Anti-Cancer Drug Sales and Growth Rate (2013-2018)
Figure Global Anti-Cancer Drug Revenue and Growth Rate (2013-2018)
Table Global Anti-Cancer Drug Sales by Regions (2013-2018)
Table Global Anti-Cancer Drug Sales Market Share by Regions (2013-2018)
Table Global Anti-Cancer Drug Revenue by Regions (2013-2018)
Figure Global Anti-Cancer Drug Revenue Market Share by Regions in 2013
Figure Global Anti-Cancer Drug Revenue Market Share by Regions in 2017
Figure North America Anti-Cancer Drug Sales and Growth Rate (2013-2018)
Figure North America Anti-Cancer Drug Revenue and Growth Rate (2013-2018)
Figure Europe Anti-Cancer Drug Sales and Growth Rate (2013-2018)
Figure Europe Anti-Cancer Drug Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Anti-Cancer Drug Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Anti-Cancer Drug Revenue and Growth Rate (2013-2018)
Figure South America Anti-Cancer Drug Sales and Growth Rate (2013-2018)
Figure South America Anti-Cancer Drug Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Anti-Cancer Drug Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Anti-Cancer Drug Revenue and Growth Rate (2013-2018)
Figure North America Anti-Cancer Drug Revenue and Growth Rate (2013-2018)
Table North America Anti-Cancer Drug Sales by Countries (2013-2018)
Table North America Anti-Cancer Drug Sales Market Share by Countries (2013-2018)
Figure North America Anti-Cancer Drug Sales Market Share by Countries in 2013
Figure North America Anti-Cancer Drug Sales Market Share by Countries in 2017
Table North America Anti-Cancer Drug Revenue by Countries (2013-2018)
Table North America Anti-Cancer Drug Revenue Market Share by Countries (2013-2018)
Figure North America Anti-Cancer Drug Revenue Market Share by Countries in 2013
Figure North America Anti-Cancer Drug Revenue Market Share by Countries in 2017
Figure United States Anti-Cancer Drug Sales and Growth Rate (2013-2018)
Figure Canada Anti-Cancer Drug Sales and Growth Rate (2013-2018)
Figure Mexico Anti-Cancer Drug Sales and Growth Rate (2013-2018)
Table North America Anti-Cancer Drug Sales by Manufacturer (2016-2017)
Figure North America Anti-Cancer Drug Sales Market Share by Manufacturer in 2016
Figure North America Anti-Cancer Drug Sales Market Share by Manufacturer in 2017
Table North America Anti-Cancer Drug Revenue by Manufacturer (2016-2017)
Figure North America Anti-Cancer Drug Revenue Market Share by Manufacturer in 2016
Figure North America Anti-Cancer Drug Revenue Market Share by Manufacturer in 2017
Table North America Anti-Cancer Drug Sales by Type (2013-2018)
Table North America Anti-Cancer Drug Sales Share by Type (2013-2018)
Table North America Anti-Cancer Drug Revenue by Type (2013-2018)
Table North America Anti-Cancer Drug Revenue Share by Type (2013-2018)
Table North America Anti-Cancer Drug Sales by Application (2013-2018)
Table North America Anti-Cancer Drug Sales Share by Application (2013-2018)
Table North America Anti-Cancer Drug Revenue by Application (2013-2018)
Table North America Anti-Cancer Drug Revenue Share by Application (2013-2018)
Figure Europe Anti-Cancer Drug Revenue and Growth Rate (2013-2018)
Table Europe Anti-Cancer Drug Sales by Countries (2013-2018)
Table Europe Anti-Cancer Drug Sales Market Share by Countries (2013-2018)
Table Europe Anti-Cancer Drug Revenue by Countries (2013-2018)
Figure Europe Anti-Cancer Drug Revenue Market Share by Countries in 2016
Figure Europe Anti-Cancer Drug Revenue Market Share by Countries in 2017
Figure Germany Anti-Cancer Drug Sales and Growth Rate (2013-2018)
Figure UK Anti-Cancer Drug Sales and Growth Rate (2013-2018)
Figure France Anti-Cancer Drug Sales and Growth Rate (2013-2018)
Figure Russia Anti-Cancer Drug Sales and Growth Rate (2013-2018)
Figure Italy Anti-Cancer Drug Sales and Growth Rate (2013-2018)
Table Europe Anti-Cancer Drug Sales by Manufacturer (2016-2017)
Figure Europe Anti-Cancer Drug Sales Market Share by Manufacturer in 2016
Figure Europe Anti-Cancer Drug Sales Market Share by Manufacturer in 2017
Table Europe Anti-Cancer Drug Revenue by Manufacturer (2016-2017)
Figure Europe Anti-Cancer Drug Revenue Market Share by Manufacturer in 2016
Figure Europe Anti-Cancer Drug Revenue Market Share by Manufacturer in 2017
Table Europe Anti-Cancer Drug Sales by Type (2013-2018)
Table Europe Anti-Cancer Drug Sales Share by Type (2013-2018)
Table Europe Anti-Cancer Drug Revenue by Type (2013-2018)
Table Europe Anti-Cancer Drug Revenue Share by Type (2013-2018)
Table Europe Anti-Cancer Drug Sales by Application (2013-2018)
Table Europe Anti-Cancer Drug Sales Share by Application (2013-2018)
Table Europe Anti-Cancer Drug Revenue by Application (2013-2018)
Table Europe Anti-Cancer Drug Revenue Share by Application (2013-2018)
Figure Asia-Pacific Anti-Cancer Drug Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Anti-Cancer Drug Sales by Countries (2013-2018)
Table Asia-Pacific Anti-Cancer Drug Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Anti-Cancer Drug Sales Market Share by Countries 2017
Table Asia-Pacific Anti-Cancer Drug Revenue by Countries (2013-2018)
Figure Asia-Pacific Anti-Cancer Drug Revenue Market Share by Countries 2017
Figure China Anti-Cancer Drug Sales and Growth Rate (2013-2018)
Figure Japan Anti-Cancer Drug Sales and Growth Rate (2013-2018)
Figure Korea Anti-Cancer Drug Sales and Growth Rate (2013-2018)
Figure India Anti-Cancer Drug Sales and Growth Rate (2013-2018)
Figure Southeast Asia Anti-Cancer Drug Sales and Growth Rate (2013-2018)
Table Asia-Pacific Anti-Cancer Drug Sales by Manufacturer (2016-2017)
Figure Asia-Pacific Anti-Cancer Drug Sales Market Share by Manufacturer in 2016
Figure Asia-Pacific Anti-Cancer Drug Sales Market Share by Manufacturer in 2017
Table Asia-Pacific Anti-Cancer Drug Revenue by Manufacturer (2016-2017)
Figure Asia-Pacific Anti-Cancer Drug Revenue Market Share by Manufacturer in 2016
Figure Asia-Pacific Anti-Cancer Drug Revenue Market Share by Manufacturer in 2017
Table Asia-Pacific Anti-Cancer Drug Sales by Type (2013-2018)
Table Asia-Pacific Anti-Cancer Drug Sales Share by Type (2013-2018)
Table Asia-Pacific Anti-Cancer Drug Revenue by Type (2013-2018)
Table Asia-Pacific Anti-Cancer Drug Revenue Share by Type (2013-2018)
Table Asia-Pacific Anti-Cancer Drug Sales by Application (2013-2018)
Table Asia-Pacific Anti-Cancer Drug Sales Share by Application (2013-2018)
Table Asia-Pacific Anti-Cancer Drug Revenue by Application (2013-2018)
Table Asia-Pacific Anti-Cancer Drug Revenue Share by Application (2013-2018)
Figure South America Anti-Cancer Drug Revenue and Growth Rate (2013-2018)
Table South America Anti-Cancer Drug Sales by Countries (2013-2018)
Table South America Anti-Cancer Drug Sales Market Share by Countries (2013-2018)
Figure South America Anti-Cancer Drug Sales Market Share by Countries in 2017
Table South America Anti-Cancer Drug Revenue by Countries (2013-2018)
Table South America Anti-Cancer Drug Revenue Market Share by Countries (2013-2018)
Figure South America Anti-Cancer Drug Revenue Market Share by Countries in 2017
Figure Brazil Anti-Cancer Drug Sales and Growth Rate (2013-2018)
Figure Argentina Anti-Cancer Drug Sales and Growth Rate (2013-2018)
Figure Colombia Anti-Cancer Drug Sales and Growth Rate (2013-2018)
Table South America Anti-Cancer Drug Sales by Manufacturer (2016-2017)
Figure South America Anti-Cancer Drug Sales Market Share by Manufacturer in 2016
Figure South America Anti-Cancer Drug Sales Market Share by Manufacturer in 2017
Table South America Anti-Cancer Drug Revenue by Manufacturer (2016-2017)
Figure South America Anti-Cancer Drug Revenue Market Share by Manufacturer in 2016
Figure South America Anti-Cancer Drug Revenue Market Share by Manufacturer in 2017
Table South America Anti-Cancer Drug Sales by Type (2013-2018)
Table South America Anti-Cancer Drug Sales Share by Type (2013-2018)
Table South America Anti-Cancer Drug Revenue by Type (2013-2018)
Table South America Anti-Cancer Drug Revenue Share by Type (2013-2018)
Table South America Anti-Cancer Drug Sales by Application (2013-2018)
Table South America Anti-Cancer Drug Sales Share by Application (2013-2018)
Table South America Anti-Cancer Drug Revenue by Application (2013-2018)
Table South America Anti-Cancer Drug Revenue Share by Application (2013-2018)
Figure Middle East and Africa Anti-Cancer Drug Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Anti-Cancer Drug Sales by Countries (2013-2018)
Table Middle East and Africa Anti-Cancer Drug Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Anti-Cancer Drug Sales Market Share by Countries in 2017
Table Middle East and Africa Anti-Cancer Drug Revenue by Countries (2013-2018)
Table Middle East and Africa Anti-Cancer Drug Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Anti-Cancer Drug Revenue Market Share by Countries in 2013
Figure Middle East and Africa Anti-Cancer Drug Revenue Market Share by Countries in 2017
Figure Saudi Arabia Anti-Cancer Drug Sales and Growth Rate (2013-2018)
Figure UAE Anti-Cancer Drug Sales and Growth Rate (2013-2018)
Figure Egypt Anti-Cancer Drug Sales and Growth Rate (2013-2018)
Figure Nigeria Anti-Cancer Drug Sales and Growth Rate (2013-2018)
Figure South Africa Anti-Cancer Drug Sales and Growth Rate (2013-2018)
Table Middle East and Africa Anti-Cancer Drug Sales by Manufacturer (2016-2017)
Figure Middle East and Africa Anti-Cancer Drug Sales Market Share by Manufacturer in 2016
Figure Middle East and Africa Anti-Cancer Drug Sales Market Share by Manufacturer in 2017
Table Middle East and Africa Anti-Cancer Drug Revenue by Manufacturer (2016-2017)
Figure Middle East and Africa Anti-Cancer Drug Revenue Market Share by Manufacturer in 2016
Figure Middle East and Africa Anti-Cancer Drug Revenue Market Share by Manufacturer in 2017
Table Middle East and Africa Anti-Cancer Drug Sales by Type (2013-2018)
Table Middle East and Africa Anti-Cancer Drug Sales Share by Type (2013-2018)
Table Middle East and Africa Anti-Cancer Drug Revenue by Type (2013-2018)
Table Middle East and Africa Anti-Cancer Drug Revenue Share by Type (2013-2018)
Table Middle East and Africa Anti-Cancer Drug Sales by Application (2013-2018)
Table Middle East and Africa Anti-Cancer Drug Sales Share by Application (2013-2018)
Table Middle East and Africa Anti-Cancer Drug Revenue by Application (2013-2018)
Table Middle East and Africa Anti-Cancer Drug Revenue Share by Application (2013-2018)
Table Global Anti-Cancer Drug Sales by Type (2013-2018)
Table Global Anti-Cancer Drug Sales Share by Type (2013-2018)
Table Global Anti-Cancer Drug Revenue by Type (2013-2018)
Table Global Anti-Cancer Drug Revenue Share by Type (2013-2018)
Figure Global Avastin Sales Growth (2013-2018)
Figure Global Avastin Price (2013-2018)
Figure Global Rituxan Sales Growth (2013-2018)
Figure Global Rituxan Price (2013-2018)
Figure Global Herceptin Sales Growth (2013-2018)
Figure Global Herceptin Price (2013-2018)
Figure Global Alimta Sales Growth (2013-2018)
Figure Global Alimta Price (2013-2018)
Table Global Anti-Cancer Drug Sales by Application (2013-2018)
Table Global Anti-Cancer Drug Sales Share by Application (2013-2018)
Figure Global Hospital Sales Growth (2013-2018)
Figure Global Clinic Sales Growth (2013-2018)
Figure Global Home Care Sales Growth (2013-2018)
Figure Global Anti-Cancer Drug Sales, Revenue and Growth Rate (2018-2023)
Table Global Anti-Cancer Drug Sales Forecast by Regions (2018-2023)
Table Global Anti-Cancer Drug Market Share Forecast by Regions (2018-2023)
Figure North America Sales Anti-Cancer Drug Market Forecast (2018-2023)
Figure Europe Sales Anti-Cancer Drug Market Forecast (2018-2023)
Figure Asia-Pacific Sales Anti-Cancer Drug Market Forecast (2018-2023)
Figure South America Sales Anti-Cancer Drug Market Forecast (2018-2023)
Figure Middle East and Africa Sales Anti-Cancer Drug Market Forecast (2018-2023)
Table Global Anti-Cancer Drug Sales Forecast by Type (2018-2023)
Table Global Anti-Cancer Drug Market Share Forecast by Type (2018-2023)
Table Global Anti-Cancer Drug Sales Forecast by Application (2018-2023)
Table Global Anti-Cancer Drug Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List